Managed Access Programs for AIN457, Secukinumab

Extension Study to Assess Effects of Non-interrupted Versus Interrupted and Long Term Treatment of Two Dose Regimes of Secukinumab in Subjects With Hidradenitis Suppurativa

NCT04179175 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Efficacy and Safety of SCT650C in Participants With Moderate to Severe Hidradenitis Suppurativa

NCT07244510 ·Status: RECRUITING ·Phase: PHASE2

A Randomized Trial Comparing the Efficacy and Safety of Secukinumab with Tofacitinib in the Treatment of Moderate to Severe Hidradenitis Suppurativa in Chinese Patients

NCT06707246 ·Status: RECRUITING ·Phase: NA

Study to Collect in a Real-world populatIon Data on the Treatment Pattern of Secukinumab in Adult Patients With Moderate to Severe Hidradenitis Suppurativa (HS) in Routine Clinical Practice in the Russian Federation

NCT06517732 ·Status: ACTIVE_NOT_RECRUITING

Efficacy and Safety Study of BDB-001 Injection in Patients With Moderate to Severe Hidradenitis Suppurativa (HS)

NCT05093855 ·Status: COMPLETED ·Phase: PHASE2

Short-term Treatment Satisfaction in Hidradenitis Suppurativa Patients Initiated on Cosentyx in Routine Clinical Practice in Saudi Arabia

NCT06785779 ·Status: RECRUITING

A Study Investigating Long-term Treatment With Spesolimab in People With a Skin Disease Called Hidradenitis Suppurativa Who Completed a Previous Clinical Trial

NCT04876391 ·Status: COMPLETED ·Phase: PHASE2

Study of Single Doses of SBT777101 in Subjects With Hidradenitis Suppurativa

NCT06361836 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

A Study to Assess Disease Activity and Safety of Subcutaneous Lutikizumab (ABT-981) in Adult Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-Tumor Necrosis Factor (TNF) Therapy and Who Are Naïve to Biologic Therapy

NCT05139602 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Open Label Study to Assess the Effect of Secukinumab in Moderate to Severe Papulopustular Rosacea

NCT03079531 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Study of Zasocitinib in Adults With Hidradenitis Suppurativa

NCT07244263 ·Status: RECRUITING ·Phase: PHASE2

A Study to Explore the Safety, Tolerability, Efficacy, and Pharmacokinetics of LT-002-158 Tablets in Chinese Adult Patients With Hidradenitis Suppurativa

NCT06932003 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2

Study to Evaluate Tulisokibart for Hidradenitis Suppurativa (MK-7240-012)

NCT06956235 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Intralesional Diode Laser Treatment of Fistulas in Hidradenitis Suppurativa

NCT04508374 ·Status: UNKNOWN ·Phase: NA

Capsule Microbiota Transplant Therapy for Hidradenitis Suppurativa

NCT06058520 ·Status: RECRUITING ·Phase: EARLY_PHASE1

Study to Compare Two Treatments for Axillary Hidradenitis Suppurativa: Carbon Dioxide Laser Versus Surgical Deroofing

NCT02163746 ·Status: COMPLETED ·Phase: NA

Gentian Violet Treatment for Hidradenitis Suppurativa

NCT04388163 ·Status: WITHDRAWN ·Phase: PHASE2

Study of the Immunomodulation in the Hidradenitis Suppurativa and Evaluation of a New Therapeutic Strategy

NCT05208099 ·Status: NOT_YET_RECRUITING

Safety, Tolerability, Pharmacokinetics, Immunogenicity and Efficacy of STP705 in Adult Patients With Hypertrophic Scars

NCT05196373 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Safety and Treatment of Cryoinsufflation in Treatment of Hidradenitis Suppurativa

NCT05830149 ·Status: TERMINATED ·Phase: NA

Brivekimig for the Treatment of Moderate to Severe Hidradenitis Suppurativa

NCT07170917 ·Status: RECRUITING ·Phase: PHASE2

Safety and Efficacy Study of BDB-001 Injection in Patients With Moderate to Severe Hidradenitis Suppurativa (HS)

NCT05103423 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Treatment of Epidermoid Cysts

NCT05597995 ·Status: UNKNOWN ·Phase: PHASE2

Feasibility Study on Radiofrequency-Based Selective Electrothermolysis to Investigate Its Effects on Human Skin

NCT05066113 ·Status: RECRUITING ·Phase: NA

A Study to Evaluate RIST4721 in Hidradenitis Suppurativa (HS)

NCT05348681 ·Status: TERMINATED ·Phase: PHASE2